Gopal Gupta is a Urologist in Melrose Park, Illinois. Dr. Gupta is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), Prostate Cancer, Nephrectomy, and Cystectomy. Dr. Gupta is currently accepting new patients.

Dr. Michael A. Carducci is the AEGON Professor in Prostate Cancer Research at the Johns Hopkins University School of Medicine. He serves as the Vice Chair of Solid Tumor Oncology in the Department of Oncology. Dr. Carducci has an expertise in various types of cancer including prostate, kidney, and testicular. He also has an expertise in clinical trials, pain and palliative care for oncology, urological oncology, urology and medical oncology. A graduate of Georgetown University, Dr. Carducci received his medical degree with high distinction from Wayne State University School of Medicine. He completed an internal medicine internship, residency and chief residency at the University of Colorado Health Sciences Center. He went on to complete medical oncology and research fellowships at the Johns Hopkins Oncology Center at Johns Hopkins Hospital. He was promoted to Professor of Oncology and Urology in 2008 and installed into the inaugural AEGON Professorship in Prostate Cancer Research in 2009. He served as Co-Director of the GU Oncology program until 2013. In 2013, he assumed the leadership role of Associate Director for Clinical Research until being named Vice-Chair of Solid Tumor Oncology in 2024. A fellow of the American College of Physicians and a fellow of the American Society of Clinical Oncology, Dr. Carducci has received peer-reviewed funding for his clinical research from the National Cancer Institute, Department of Defense, and the Prostate Cancer Foundation. Mentorship of students, fellows, and junior faculty has been another focus of Dr. Carducci’s career in medicine, receiving numerous teaching awards. Dr. Carducci received the Michaele Christian Award and Lectureship for Oncology Drug Development at the National Cancer Institute in 2011. He chaired the Genitourinary Oncology Committee of ECOG-ACRIN from 2011-2024. In this role, he served on the GU Steering Committee for the NCI. Dr. Carducci is a member of the Investigational Drug Steering Committee for the NCI, and chaired that Committee for four years. He served as Associate Editor for GU Cancers for the Journal of Clinical Oncology from 2013-2024. Overall, his clinical research focus is on the development and evaluation of new therapies for urologic cancers. Incorporation of pharmacodynamics, novel biomarkers, and targeted imaging has been key elements of many of the trials led by Dr. Carducci. To complete these studies, Dr. Carducci facilitates and brings together a multidisciplinary team from urologists, radiation oncologists, pathologists, biostatisticians, and medical oncologists. Other areas of interest include palliative and end of life care, survivorship, and use of patient reported outcomes in clinical research and care. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Carducci is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), Hormone Replacement Therapy (HRT), and Orchiectomy.

Mark Waples is a Urologist in Milwaukee, Wisconsin. Dr. Waples is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Ureterocele, WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, Nephrectomy, and Reconstructive Urology Surgery.

Dr. Zhao believes in providing the best cancer care through multidisciplinary, evidence-based — yet personalized — approaches. Dr. Zhao is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Variegate Porphyria, Hereditary Coproporphyria, Porphyria, and WT1-Related Wilms Tumor Syndromes.

Dr. Porter provides state-of-the-art, minimally invasive treatment options to patients with urologic cancer and stone disease to reduce the pain and recovery from surgical treatment. He stays current on the latest available treatments by teaching at national and international urologic meetings as well as publishing his outcomes. Dr. Porter was the 2023 recipient of the Menon Award in Robotic Urologic Surgery. Dr. Porter is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Clear Cell Sarcoma, Wilms Tumor, Renal Cell Carcinoma (RCC), Vasectomy, and Reconstructive Urology Surgery.

Timothy Lestingi is a Hematologist and an Oncologist in Park Ridge, Illinois. Dr. Lestingi is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Chromophobe Renal Cell Carcinoma, Clear Cell Sarcoma, Ureteroscopy, and Gastrostomy.

Daniel George is a Urologist and a Hematologist in Durham, North Carolina. Dr. George is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Nephrectomy, and Orchiectomy. Dr. George is currently accepting new patients.

Richard Vanlangendonck is a Urologist in Heber City, Utah. Dr. Vanlangendonck has been practicing medicine for over 30 years and is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), Reconstructive Urology Surgery, and Nephrectomy. Dr. Vanlangendonck is currently accepting new patients.

Michael Harrison is an Oncologist and a Hematologist in Durham, North Carolina. Dr. Harrison is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Prostate Cancer, Familial Prostate Cancer, WT1-Related Wilms Tumor Syndromes, and Prostatectomy. Dr. Harrison is currently accepting new patients.

Andrew Armstrong is an Oncologist in Durham, North Carolina. Dr. Armstrong is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Orchiectomy, and Prostatectomy. Dr. Armstrong is currently accepting new patients.

. Dr. Coursey is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Congenital Mesoblastic Nephroma, Familial Wilms Tumor 2, Renal Cell Carcinoma (RCC), Nephrectomy, and Reconstructive Urology Surgery.

Thomas Polascik is a Urologist in Durham, North Carolina. Dr. Polascik is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Nephrectomy. Dr. Polascik is currently accepting new patients.

Joseph Clark is a Hematologist Oncology specialist and a Hematologist in Maywood, Illinois. Dr. Clark is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Melanoma, Renal Cell Carcinoma (RCC), Nasopharyngeal Carcinoma, Bone Marrow Aspiration, and Gastrostomy. Dr. Clark is currently accepting new patients.

Kirsten Greene is a Urologist in Charlottesville, Virginia. Dr. Greene is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. Her top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Ureterocele, Nephrectomy, and Reconstructive Urology Surgery. Dr. Greene is currently accepting new patients.

Jeffrey Tomasini is a Urologist in Sheboygan, Wisconsin. Dr. Tomasini is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Familial Prostate Cancer, Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), Ureteroscopy, and Vasectomy.

"Dr. Grant Taylor has been practicing urology in the Tri-Cities area since 2005. He says, ""We love the people in this area and the beauty around us. We enjoy outdoor activities, and this area affords us many opportunities to get outside."" Dr. Taylor's personal philosophy for treating patients is, ""Listen first and understand why they are here seeing us and the impact this issue has on them. This allows us to have aligned goals for their care."" He says, ""We all have difficult days in our lives. This is a sacred space that we as physicians are in with our patients, and we have the privilege of walking that with them and providing the kind of care we would want for our family.". Dr. Taylor is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Oncocytoma, Urinary Tract Infection in Children, UPJ Obstruction, Ureteroscopy, and Reconstructive Urology Surgery.

. Dr. Tongco is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Oncocytoma, UPJ Obstruction, Muscle Invasive Bladder Cancer, Ureteroscopy, and Reconstructive Urology Surgery.

. Dr. Bermejo is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Familial Prostate Cancer, Ureteroscopy, and Reconstructive Urology Surgery.

. Dr. Musgrave is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. Her top areas of expertise are Paget Disease of the Breast, Thrombocytopenia, Neuroendocrine Tumor, and Angiosarcoma.

Jerry Liu is a Hematologist and an Oncologist in Crystal Lake, Illinois. Dr. Liu is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Paget Disease of the Breast, Colorectal Cancer, Familial Colorectal Cancer, Anemia, and Bone Marrow Aspiration.